Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy – Six months follow-up result

Background: Ischemic cardiomyopathy is a growing burden in third world countries. So far, benefits of trimetazidine in this group of patients have been suggested by clinical trials mainly conducted in Europe. We evaluated the effect of trimetazidine on ischemic dilated cardiomyopathy in our populati...

Full description

Bibliographic Details

Published in:	Indian Heart Journal
Main Authors:	A. Momen, M. Ali, P.K. Karmakar, M.Z. Ali, A. Haque, M.R. Khan, M.I. Khalil, M.S. Hossain, R.M. Huda, M.N. Goni
Format:	Article
Language:	English
Published:	Elsevier 2016-11-01
Subjects:	Trimetazidine Ischemic cardiomyopathy Chronic heart failure
Online Access:	http://www.sciencedirect.com/science/article/pii/S001948321600122X